Press Release

« Back

Travere Therapeutics to Report First Quarter 2022 Financial Results

Apr 28, 2022

SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report first quarter 2022 financial results on Thursday, May 5, 2022, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Conference Call Information

Date: Thursday, May 5, 2022
Time: 4:30 p.m. ET
Dial-in numbers: +1 (800) 289-0720 (U.S.) or +1 (313) 209-5140 (International)
Confirmation code: 7273768
Live webcast: Travere.com in the “Events & Presentations” section of the “Investors” page

A replay of the call will be available from 7:30 p.m. ET, May 5, 2022, to 7:30 p.m. ET, May 12, 2022. The replay number is +1 (888) 203-1112 (U.S.) or +1 (719) 457-0820 (International), confirmation code 7273768.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Chris Cline, CFA                                 
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879                                        
IR@travere.com 

 


Primary Logo

Source: Travere Therapeutics, Inc.